Llewelyn, Martin

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Abani, O., Abbas, A., Abbas, F., Abbas, M., Abbasi, S., Abbass, H., Abbott, A., Abdallah, N., Abdelaziz, A., Abdelfattah, M., et al. (2021) · The Lancet

COVID-19 Clinical Research StudiesRespiratory Support and Mechanisms

Cited by 1,983

Influence of Polymorphism in the Genes for the Interleukin (IL)-1 Receptor Antagonist and IL-1β on Tuberculosis

Wilkinson, R. J., Patel, P., Llewelyn, M., Hirsch, C. S., Pasvol, G., Snounou, G., Davidson, R. N., & Toossi, Z. (1999) · The Journal of Experimental Medicine

Tuberculosis Research and EpidemiologyGenetic Associations and Epidemiology

Cited by 295

Duration of antibiotic treatment for common infections in English primary care: cross sectional analysis and comparison with guidelines

Pouwels, K. B., Hopkins, S., Llewelyn, M. J., Walker, A. S., McNulty, C. A., & Robotham, J. V. (2019) · BMJ

Antibiotic Use and ResistanceHealthcare cost, quality, practices

Cited by 126

Optimizing design of research to evaluate antibiotic stewardship interventions: consensus recommendations of a multinational working group

Schweitzer, V. A., van Werkhoven, C. H., Rodríguez Baño, J., Bielicki, J., Harbarth, S., Hulscher, M., Huttner, B., Islam, J., Little, P., Pulcini, C., et al. (2020) · Clinical Microbiology and Infection

Antibiotic Use and ResistanceHealth Policy Implementation Science

Cited by 73